Cysteine challenge testing: a powerful tool for examining oral malodour processes and treatments in vivo.
Gram-negative oral bacteria rapidly produce the odorant hydrogen sulphide from cysteine. It provides a major part of the oral malodour bouquet while causing a corresponding decrease in the oxidation-reduction potential (Eh). A low Eh favours oral putrefaction and malodour occurrence. Challenge testing with cysteine (5ml of 6mM for 30 seconds) enabled evaluation of: the contribution of tongue and teeth bacteria to overall oral malodour; the effectiveness of tongue and tooth brushing, tooth scraping, gum chewing and mouthrinsing with different agents in reducing oral malodour. Successive cysteine challenge tests for 20 minute periods at selected times in a seven hour experiment were effective for assessing the magnitude and duration of an agent's effectiveness. Brushing the teeth reduced malodour modestly. So did tongue scraping and gum chewing. In contrast, brushing the tongue dorsum, especially the posterior half was remarkably effective, which confirmed it as a major site of oral malodour contribution. Rinses containing various actives showed wide variation in effectiveness. The experiments demonstrated that cysteine challenge testing is potentially a aluable tool for assessing the ability of the oral bacteria to produce malodour and for assessing agents designed to inhibit such production.
Kleinberg
I
I
Department of Oral Biology and Pathology, School of Dental Medicine, State University of New York, Stony Brook 11794-8702, USA. Israel.Kleinberg@sunysb.edu
Codipilly
D M
DM
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002594:Cetylpyridinium / Q000627:therapeutic use; D002638:Chewing Gum; D002710:Chlorhexidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002712:Chlorides / Q000627:therapeutic use; D003545:Cysteine / Q000378:metabolism; D003742:Dental Devices, Home Care; D004338:Drug Combinations; D006090:Gram-Negative Bacteria / Q000378:metabolism; D006209:Halitosis / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy; D006801:Humans; D006862:Hydrogen Sulfide / Q000378:metabolism; D009067:Mouthwashes / Q000627:therapeutic use; D009910:Oral Hygiene / Q000295:instrumentation; D010084:Oxidation-Reduction; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D012973:Sodium Hypochlorite / Q000627:therapeutic use; D014059:Tongue / Q000382:microbiology; D014070:Tooth / Q000382:microbiology; D014099:Toothbrushing; D016896:Treatment Outcome; D017967:Zinc Compounds / Q000627:therapeutic use
D000891:Anti-Infective Agents, Local; D002638:Chewing Gum; D002712:Chlorides; D004338:Drug Combinations; D009067:Mouthwashes; D000644:Quaternary Ammonium Compounds; C094642:Scope mouthwash; D017967:Zinc Compounds; C016837:zinc chloride; D002594:Cetylpyridinium; D012973:Sodium Hypochlorite; D003545:Cysteine; C010882:chlorhexidine gluconate; D002710:Chlorhexidine; D006862:Hydrogen Sulfide